The Veterinary Vaccines Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increase in Zoonotic Diseases
The number, frequency, and variety of zoonotic disease outbreaks have increased dramatically during the last century. These occurrences, which are caused by infections spilling from animal hosts to humans, may have increased by more than thrice in the previous decade, with the incidence of novel zoonotic illnesses infecting humans quadrupling within the same time period. Currently, zoonotic illnesses account for 60% of all new infectious diseases in humans. Animal viruses can infect people directly or indirectly, depending on whether they come into touch with wild or farmed animals. These intermediary hosts function as “mixing vessels,” allowing diseases to evolve genetically and infect humans. And, in recent times, human-to-animal interaction has expanded substantially, increasing the potential of zoonotic disease epidemics. Growing zoonotic diseases has boosted the demand for veterinary vaccines globally.
DNA Vaccine Represents New Frontier In Vaccine Technology
Vaccines based on DNA represent a new frontier in vaccine technology. This technique has a significant use in the veterinary field. DNA vaccines have already made inroads into several areas of veterinary medicine. However, while creating DNA vaccines for animals, numerous critical concerns must be addressed, including whether the vaccine is efficacious and cost effective in comparison to already available alternatives. Another key topic to address is how to utilise this new technology in a variety of scenarios, from the domestic pet to individual fish in fisheries with thousands of animals, to wildlife disease management programmes. In certain situations, DNA vaccines offer an intriguing alternative for immunisation, but in others, the current methods are not enough. A variety of veterinary diseases and the development being made using DNA vaccine technology. Moreover, DNA vaccines can be used for simultaneous immunizations against many pathogens and are relatively less expensive to manufacture and store. Hence, in near future DNA vaccines are expected to witness a significant growth.
What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the veterinary vaccines market evolving?
• What is driving and restraining the veterinary vaccines market?
• How each veterinary vaccines submarket segment will grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each veterinary vaccines submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading veterinary vaccines markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the veterinary vaccines projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implication of veterinary vaccines projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the veterinary vaccines market?
• Where is the veterinary vaccines market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?
You need to discover how this will impact the veterinary vaccines market today, and over the next 10 years:
• Our 444-page report provides 310 tables and 290 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the veterinary vaccines market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Delivers exclusive COVID-19 variations economic data specific to your market.
To access the data contained in this document please email contactus@visiongain.com
Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising veterinary vaccines prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.
Global Veterinary Vaccines Market (COVID Impact Analysis) by Companion Animal
• Dogs
• Cats
Global Veterinary Vaccines Market (COVID Impact Analysis) by Technology
• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Other Technology
Global Veterinary Vaccines Market (COVID Impact Analysis) by Type
• Porcine Vaccines
• Poultry Vaccine
• Livestock Vaccine
• Companion Animal Vaccine
• Aquaculture Vaccines
• Other Type
Global Veterinary Vaccines Market (COVID Impact Analysis) by Livestock
• Cattle
• Pigs
• Poultry
• Other Livestock
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 20 leading national markets:
North America Veterinary Vaccines Market, 2022 to 2032 Market Outlook
• U.S. Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Canada Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Mexico Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
Europe Veterinary Vaccines Market, 2022 to 2032 Market Outlook
• Germany Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Spain Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• United Kingdom Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• France Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Italy Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Rest of Europe Market Forecast & COVID Impact Analysis
Asia Pacific Veterinary Vaccines Market, 2022 to 2032 Market Outlook
• China Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Japan Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• India Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Australia Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• South Korea Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Rest of Asia Pacific Market Forecast & COVID Impact Analysis
LAMEA Veterinary Vaccines Market, 2022 to 2032 Market Outlook
• Brazil Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Turkey Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Saudi Arabia Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• South Africa Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• UAE Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Rest of Latin America, Middle East and Africa
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Veterinary Vaccines Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Zoetis Inc.
• Virbac Pharmaceutical
• Boehringer Ingelheim Animal Health
• Elanco Animal Health Incorporated
• Intas Pharmaceuticals Ltd
• Merck Animal Health
• Indian Immunologicals Ltd (IIL)
• Phibro Animal Health Corporation (Phibro)
• Biogenesis Bago SA
• Hester Biosciences
• Hipra Pharmaceutical Company
Overall world revenue for Veterinary Vaccines Market, 2022 to 2032 in terms of value the market will surpass US$xx million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Veterinary Vaccines Market, 2022 to 2032 Market report helps you?
In summary, our 444+ page report provides you with the following knowledge:
• Revenue forecasts for Veterinary Vaccines Market, 2022 to 2032 Market include forecasts for companion animal, technology, type, livestock each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for 4 regional and 20 key national markets – See forecasts for the Veterinary Vaccines Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 12 of the major companies involved in the Veterinary Vaccines Market, 2022 to 2032 Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Veterinary Vaccines Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Veterinary Vaccines Market Report 2022-2032: Forecasts by Companion Animal (Dogs, Cats), by Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other), by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Other), by Livestock (Cattle, Pigs, Poultry) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Introduction to Veterinary Vaccines Market
1.2 Global Veterinary Vaccine Market Overview
1.3 What are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Veterinary Vaccines Market Definition
1.5.1 Vaccination
1.5.2 Veterinary Vaccines
1.6 Why You Should Read This Report
1.7 What This Report Delivers
1.8 Key Questions Answered By This Analytical Report Include:
1.9 Who is This Report for?
1.10 Research Methodology
1.11 Frequently Asked Questions (FAQs)
1.12 Associated Visiongain Reports
1.13 About Visiongain
2 Executive Summary
2.1 Introduction
3 Global Market Dynamics
3.1 Current Trends in the Global Market
3.1.1 The Possible Benefits Of Increasing Animal Wellbeing
3.1.2 New Vaccine Technologies to Combat Outbreak Situations
3.2 Market Driving Factors
3.2.1 Growing Interest For The Veterinary Vaccinology Community
3.2.2 Vaccination For Pet Animals Needs More Attention in Developing countries
3.2.3 The Increase In Zoonotic Diseases
3.2.4 Growing demand for Animal derived Protein
3.3 Market Restraining Factors
3.3.1 Lack of Immunization Adaptation Among Smallholder Farmers
3.3.2 The Complexity And Cost Of Vaccine Manufacturing
3.3.3 Hurdles In The Lengthy And Costly Path To A Licenced Vaccine
3.4 Opportunities in the Global Market
3.4.1 DNA Vaccine Represents New Frontier In Vaccine Technology
3.4.2 Modern Vaccine Strategies in Animal Health
3.5 Challenges in the Global Market
3.5.1 Virulent Organisms Are The Most Unambiguous Way To Measure the DOI (Minimum Duration of Immunity)
3.5.2 Highly Advanced Technology, Availability of Skilled labour and Product Recalls Makes Vaccine manufacturing a capital intensive market
3.5.3 Limited Understanding of Immune Response in Animals
3.5.4 Regulatory Approval Processes Also Have An Important Impact On The Decision
3.6 SWOT Analysis for Global Market
3.7 PEST Analysis for Global Market
3.8 Porter’s Five Forces
3.8.1 Threats of New Entrants- Medium
3.8.2 Bargaining Power of Suppliers- high
3.8.3 Bargaining Power of Buyers- High to Medium
3.8.4 Threats of Substitute - Medium
3.8.5 Rivalry Among The Existing Competitors - High
4 Global Veterinary Vaccines Market Analysis
4.1 Global Market Outlook
4.1.1 Global focus on current developments
4.1.2 Strategies to Increase Adoption Of Animal Vaccines By Smallholder Farmers With Focus On Neglected Diseases And Marginalized Populations
4.2 Global Market Size Estimation and Forecast by Value
4.2.1 Pre-COVID-19 Market Scenario
4.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5 Global Market Size Estimation and Forecast by Region
5.1.1 Pre-COVID-19 Market Scenario
5.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Veterinary Vaccines Market by Companion Animal
6.1.1 Dogs
6.1.2 Cat
6.1.3 Pre-COVID-19 Market Scenario
6.1.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Veterinary Vaccines Market by Technology
7.1.1 Live Attenuated Vaccines
7.1.2 Inactivated Vaccines
7.1.3 Toxoid Vaccines
7.1.4 Recombinant Vaccines
7.1.5 Other Technology
7.1.5.1 Attenuated Vaccines
7.1.5.2 Subunit Vaccines
7.1.5.3 DNA vaccines
7.1.5.4 Gene-deleted Vaccines
7.1.5.5 Virus-vectored Vaccines
7.1.6 Pre-COVID-19 Market Scenario
7.1.7 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Veterinary Vaccines Market by Type
8.1.1 Poultry Viral Vaccines
8.1.2 Porcine Viral Vaccines
8.1.3 Bovine Viral Vaccines
8.1.4 Livestock Vaccine
8.1.5 Companion Animal Vaccine
8.1.6 Aquaculture Vaccines
8.1.7 Other Type
8.1.8 Pre-COVID-19 Market Scenario
8.1.9 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Veterinary Vaccines Market by Livestock
9.1.1 Cattle
9.1.2 Poultry
9.1.3 Fisheries
9.1.4 Other Livestock
9.1.5 Pre-COVID-19 Market Scenario
9.1.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 North America Veterinary Vaccines Market Analysis
10.1 North America Market Outlook
10.1.1 Introduction
10.1.2 Boehringer Ingelheim Animal Health USA Establishes Pawru, Inc.
10.1.3 The U.S. is Planning Vaccine Bank to Guard against Foot-And-Mouth Disease
10.1.4 Pre-COVID-19 Market Scenario
10.1.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.2 North America Veterinary Vaccines Market Analysis by Country
10.2.1 Pre-COVID-19 Market Scenario
10.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.3 North America Veterinary Vaccines Market by Companion Animal
10.3.1 Pre-COVID-19 Market Scenario
10.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.4 North America Veterinary Vaccines Market by Technology
10.4.1 Pre-COVID-19 Market Scenario
10.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.5 North America Veterinary Vaccines Market by Type
10.5.1 Pre-COVID-19 Market Scenario
10.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.6 North America Veterinary Vaccines Market by Livestock
10.6.1 Pre-COVID-19 Market Scenario
10.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.7 US Veterinary Vaccines Market Analysis
10.7.1 Merck Animal Health Launches Nasalgen®
10.7.2 Zoetis Expands Vector Vaccine Portfolio With Introduction Of POULVAC® PROCERTA™ HVT-IBD
10.7.3 Pre-COVID-19 Market Scenario
10.7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.8 Canada Veterinary Vaccines Market Analysis
10.8.1 Ingelvac Provenza™ intranasal vaccine for Swine flu
10.8.2 ERYSENG® PARVO, a new sow reproductive vaccine launched by HIPRA in Canada
10.8.3 'Time to Vaccinate' Campaign To Empower Farmers With Knowledge
10.8.4 Pre-COVID-19 Market Scenario
10.8.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.9 Mexico Veterinary Vaccines Market Analysis
10.9.1 Towards a World Free Of Dog-Transmitted Rabies
10.9.2 3-in-1 Vaccine for Poultry Launched in Mexico
10.9.3 Pre-COVID-19 Market Scenario
10.9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 Europe Veterinary Vaccines Market Analysis
11.1 Introduction
11.1.1 PREVEXXION® RN: the next generation of Marek’s disease vaccines now available in the EU and the UK
11.1.2 NASYM (by Hipra), the new BRSV strategy has started throughout Europe
11.1.3 Pre-COVID-19 Market Scenario
11.1.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.2 Europe Veterinary Vaccines Market by Country
11.2.1 Pre-COVID-19 Market Scenario
11.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.3 Europe Veterinary Vaccines Market by Companion Animal
11.3.1 Pre-COVID-19 Market Scenario
11.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.4 Europe Veterinary Vaccines Market by Technology
11.4.1 Pre-COVID-19 Market Scenario
11.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.5 Europe Veterinary Vaccines Market by Type
11.5.1 Pre-COVID-19 Market Scenario
11.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.6 Europe Veterinary Vaccines Market by Livestock
11.6.1 Pre-COVID-19 Market Scenario
11.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.7 Germany Veterinary Vaccines Market Analysis
11.7.1 Canine vaccination in Germany
11.7.2 Lack of owner compliance and high cost of vaccines are major deterrent for market growth
11.7.3 Pre-COVID-19 Market Scenario
11.7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.8 UK Veterinary Vaccines Market Analysis
11.8.1 BBSRC Under The Auspices Of Global Strategic Alliances
11.8.2 BBSRC’s (Biotechnology and Biological Sciences Research Council) Current Veterinary Vaccinology Investments
11.8.3 Pre-COVID-19 Market Scenario
11.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.9 France Veterinary Vaccines Market Analysis
11.9.1 The Main Reason For The Spread Of HPAI Viruses In The South-Eastern Region Of France
11.9.2 Pre-COVID-19 Market Scenario
11.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.10 Italy Veterinary Vaccines Market Analysis
11.10.1 Vaccination In The Control Strategy Of Bluetongue In Italy
11.10.2 HIPRA presents ERAVAC®, the new vaccine against RHDV2, in Italy
11.10.3 Pre-COVID-19 Market Scenario
11.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.11 Spain Veterinary Vaccines Market Analysis
11.11.1 HIPRA presents two new vaccines for poultry farming in Spain
11.11.2 Pre-COVID-19 Market Scenario
11.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.12 Rest of Europe Veterinary Vaccines Market Analysis
11.12.1 National Legislation Procedures For Poultry Vaccination
11.12.2 HIPRA launches ICTHIOVAC® VR/PD (vaccine against vibriosis and pasteurellosis in sea bass) in Spain, Italy, Portugal, France and Tunisia
11.12.3 Pre-COVID-19 Market Scenario
11.12.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 Asia-Pacific Veterinary Vaccines Market Analysis
12.1.1 Introduction
12.1.2 Rabies Control In South Asia Requires A One Health Approach
12.1.3 Lack of Awareness of Global Vaccination Practices in Asia
12.1.4 Pre-COVID-19 Market Scenario
12.1.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.2 Asia-Pacific Veterinary Vaccines Market by Country
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Asia-Pacific Veterinary Vaccines Market by Companion Animal
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 Asia-Pacific Veterinary Vaccines Market by Technology
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 Asia-Pacific Veterinary Vaccines Market by Type
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 Asia-Pacific Veterinary Vaccines Market by Livestock
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 China Veterinary Vaccines Market Analysis
12.7.1 Zoetis to Expand Animal Vaccine Research and Manufacturing in Suzhou, China
12.7.2 Boehringer Ingelheim Launches First Veterinary Vaccines Produced In China
12.7.3 Pre-COVID-19 Market Scenario
12.7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 India Veterinary Vaccines Market Analysis
12.8.1 Indian Immunologicals Develops Vaccine to Fight Tapeworms in Pigs
12.8.2 The Vaccine Makers Eyeing US$ 1768.69 Crore Programme
12.8.3 Pre-COVID-19 Market Scenario
12.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 Japan Veterinary Vaccines Market Analysis
12.9.1 Sumitomo Corporation expands veterinary medicine sales to Indonesia through partnership with Medion Pharma
12.9.2 Japan Donates Farm Animal Vaccines
12.9.3 Pre-COVID-19 Market Scenario
12.9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 South Korea Veterinary Vaccines Market Analysis
12.10.1 Strategies to Maintain Korea's Animal Rabies Non-Occurrence Status
12.10.2 Korea has Successfully Implemented A National Rabies Control Program Including Mass Vaccination
12.10.3 Pre-COVID-19 Market Scenario
12.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 Australia Veterinary Vaccines Market Analysis
12.11.1 In Australia, Over 140 Vaccinations Are Approved For Use In Cattle And Companion Animals
12.11.2 Pre-COVID-19 Market Scenario
12.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 Rest of Asia-Pacific Veterinary Vaccines Market Analysis
12.12.1 Growing awareness of vaccination to boost the market growth for Rest of Asia
12.12.2 Vietnam: a Sustainable Collaboration with Farmers
12.12.3 Pre-COVID-19 Market Scenario
12.12.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 LAMEA Veterinary Vaccines Market Analysis
13.1.1 Introduction
13.1.2 Saudi-Argentine JV Plans $60 Mn Animal Vaccine Manufacturing Plant in Riyadh
13.1.3 Pre-COVID-19 Market Scenario
13.1.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.2 LAMEA Veterinary Vaccines Market by Country
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 LAMEA Veterinary Vaccines Market by Companion Animal
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 LAMEA Veterinary Vaccines Market by Technology
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 LAMEA Veterinary Vaccines Market by Type
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 LAMEA Veterinary Vaccines Market by Livestock
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Brazil Veterinary Vaccines Market Analysis
13.7.1 Use Of Collar Impregnated With Insecticide For Reducing Incidence Of Leishmania Infection in Brazil
13.7.2 Pre-COVID-19 Market Scenario
13.7.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 South Africa Veterinary Vaccines Market Analysis
13.8.1 Strengthening Veterinary Services in Africa
13.8.2 Pre-COVID-19 Market Scenario
13.8.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Saudi Arabia Veterinary Vaccines Market Analysis
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 Turkey Veterinary Vaccines Market Analysis
13.10.1 Turkey: The First Veterinary Vaccine Against Canine Leishmaniosis
13.10.2 Pre-COVID-19 Market Scenario
13.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 UAE Veterinary Vaccines Market Analysis
13.11.1 Abu Dhabi Campaign Aims To Improve Immunity Among Livestock
13.11.2 Dubai-Developed Covid-19 Vaccine To Protect Animals Against Virus
13.11.3 Pre-COVID-19 Market Scenario
13.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 Rest of LAMEA Veterinary Vaccines Market Analysis
13.12.1 To Increase Productivity Of Small Family Farms In Latin America
13.12.2 Pre-COVID-19 Market Scenario
13.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 Leading Company Profiles
14.1 Growth Strategy Allows Companies to Expand Their Business
14.1.1 Growth Through Acquisitions, Expansion and Investment
14.1.2 Agreements, Contracts and Establishment
14.1.3 Strategic Alliance
14.1.4 Introduction of New Segment
14.2 Zoetis Inc.
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Company Financial Profile
14.2.4 Company Product Benchmarking
14.2.5 Company Recent Developments
14.3 Virbac Pharmaceutical
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Company Financial Profile
14.3.4 Company Product Benchmarking
14.3.5 Company Recent Developments
14.4 Boehringer Ingelheim Animal Health
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Company Financial Profile
14.4.4 Company Product Benchmarking
14.4.5 Company Recent Developments
14.5 Elanco Animal Health Incorporated
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Company Financial Profile
14.5.4 Company Product Benchmarking
14.5.5 Company Recent Developments
14.6 Intas Pharmaceuticals Ltd
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Company Financial Profile
14.6.4 Company Product Benchmarking
14.6.5 Company Recent Developments
14.7 Merck Animal Health.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Company Financial Profile
14.7.4 Company Product Benchmarking
14.7.5 Company Recent Developments
14.8 Indian Immunologicals Ltd.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Company Financial Profile
14.8.4 Company Product Benchmarking
14.8.5 Company Recent Developments
14.9 Phibro Animal Health Corporation
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Company Financial Profile
14.9.4 Company Product Benchmarking
14.9.5 Company Recent Developments
14.10 Biogenesis Bago SA
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Company Financial Profile
14.10.4 Company Product Benchmarking
14.10.5 Company Recent Developments
14.11 Hester Biosciences
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Company Financial Profile
14.11.4 Company Product Benchmarking
14.11.5 Company Recent Developments
14.12 Hipra Pharmaceutical Company
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Company Financial Profile
14.12.4 Company Product Benchmarking
14.12.5 Company Recent Developments
15 Conclusion & Recommendation
15.1 Conclusion Summary
15.2 Recommendations
15.2.1 Duration of Immunity Should Sustain for Longer Duration
15.2.2 Incessant Vaccine Research will aid in Preventive and Prompt treatment
15.2.3 Intensive Animal Production To Fulfil Global Nutritional Needs
15.3 Leading and Fastest Growing Regions
16 Glossary Terms
List of Table
Table 1 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 2 Global Veterinary Vaccines Market Snapshot, 2022 & 2032 (US$million, CAGR %)
Table 3 Global Recombinant Viral Vector Vaccines ( Manufacturers & Pathogen)
Table 4 Global DNA Vaccines ( Manufacturers & Pathogen)
Table 5 Global Recombinant Viral Vector Vaccines ( Manufacturers & Pathogen)
Table 6 DIVA Vaccines ( Manufacturers & Pathogen)
Table 7 Veterinary Vaccines SWOT Analysis
Table 8 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 9 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 10 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 11 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 12 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 13 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 14 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 15 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 16 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 17 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 18 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 19 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 20 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 21 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 22 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 23 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 24 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 25 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 26 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 27 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 28 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 29 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 30 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 31 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 32 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 33 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 34 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 35 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 36 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 37 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 38 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 39 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 40 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 41 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 42 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 43 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 44 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 45 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 46 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 47 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 48 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 49 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 50 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 51 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 52 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 53 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 54 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 55 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 56 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 57 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 58 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 59 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 60 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 61 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 62 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 63 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 64 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 65 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 66 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 67 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 68 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 69 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 70 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 71 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 72 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 73 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 74 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 75 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 76 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 77 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 78 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 79 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 80 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 81 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 82 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 83 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 84 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 85 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 86 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 87 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 88 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 89 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 90 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 91 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 92 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 93 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 94 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 95 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 96 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 97 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 98 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 99 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 100 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 101 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 102 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 103 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 104 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 105 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 106 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 107 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 108 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 109 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 110 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 111 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 112 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 113 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 114 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 115 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 116 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 117 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 118 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 119 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 120 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 121 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 122 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 123 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 124 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 125 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 126 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 127 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 128 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 129 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 130 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 131 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 132 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 133 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 134 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 135 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 136 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 137 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 138 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 139 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 140 Asia-Pacific Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 141 Asia-Pacific Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 142 Asia-Pacific Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 143 Asia-Pacific Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 144 Asia-Pacific Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 145 Asia-Pacific Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 146 Asia-Pacific Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 147 Asia-Pacific Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 148 Asia-Pacific Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 149 Asia-Pacific Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 150 Asia-Pacific Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 151 Asia-Pacific Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 152 Asia-Pacific Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 153 Asia-Pacific Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 154 Asia-Pacific Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 155 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 156 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 157 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 158 China Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 159 China Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 160 China Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 161 China Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 162 China Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 163 India Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 164 India Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 165 India Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 166 India Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 167 India Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 168 Japan Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 169 Japan Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 170 Japan Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 171 Japan Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 172 Japan Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 173 South Korea Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 174 South Korea Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 175 South Korea Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 176 South Korea Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 177 South Korea Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 178 Australia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 179 Australia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 180 Australia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 181 Australia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 182 Australia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 183 Rest of Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 184 Rest of Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 185 Rest of Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 186 Rest of Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 187 Rest of Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 188 LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 189 LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 190 LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 191 LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 192 LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 193 LAMEA Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 194 LAMEA Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 195 LAMEA Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 196 LAMEA Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 197 LAMEA Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 198 LAMEA Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 199 LAMEA Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 200 LAMEA Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 201 LAMEA Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 202 LAMEA Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 203 LAMEA Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 204 LAMEA Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 205 LAMEA Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 206 LAMEA Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 207 LAMEA Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 208 LAMEA Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 209 LAMEA Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 210 LAMEA Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 211 LAMEA Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 212 LAMEA Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 213 Brazil Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 214 Brazil Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 215 Brazil Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 216 Brazil Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 217 Brazil Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 218 South Africa Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 219 South Africa Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 220 South Africa Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 221 South Africa Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 222 South Africa Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 223 Saudi Arabia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 224 Saudi Arabia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 225 Saudi Arabia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 226 Saudi Arabia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 227 Saudi Arabia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 228 Turkey Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 229 Turkey Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 230 Turkey Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 231 Turkey Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 232 Turkey Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 233 UAE Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 234 UAE Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 235 UAE Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 236 UAE Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 237 UAE Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 238 Rest of LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 239 Rest of LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 240 Rest of LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 241 Rest of LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 242 Rest of LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 243 Leading Veterinary Vaccines Listed Company
Table 244 Business Strategy: Acquisition, Expansion and Investment
Table 245 Business Strategy: Agreement, Contracts and Establishment
Table 246 Business Strategy: Partnership, Collaboration and Joint Venture
Table 247 Business Strategy: Product Launch
Table 248 Zoetis Inc: Company Information
Table 249 Zoetis Inc: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 250 Zoetis Inc: Company Product and Service Benchmarking
Table 251 Zoetis Inc: Company Recent Developments till Jan,2022
Table 252 Virbac SA : Company Information
Table 253 Virbac SA : Company Revenue 2016-2020 (US$Mn, AGR %)
Table 254 Virbac SA : Company Product and Service Benchmarking
Table 255 Virbac SA : Company Recent Developments till Jan,2022
Table 256 Boehringer Ingelheim: Company Information
Table 257 Boehringer Ingelheim: Company Product and Service Benchmarking
Table 258 Boehringer Ingelheim: Company Recent Developments till Jan,2022
Table 259 Elanco Animal Health Incorporated: Company Information
Table 260 Elanco Animal Health Incorporated: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 261 Elanco Animal Health Incorporated: Company Product and Service Benchmarking
Table 262 Elanco Animal Health Incorporated: Company Recent Developments till Jan,2022
Table 263 Intas Pharmaceuticals Ltd: Company Information
Table 264 Intas Pharmaceuticals Ltd: Company Product and Service Benchmarking
Table 265 Intas Pharmaceuticals Ltd: Company Recent Developments till Jan,2022
Table 266 Merck & Co., Inc.: Company Information
Table 267 Merck & Co., Inc.: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 268 Merck & Co., Inc.: Company Product and Service Benchmarking
Table 269 Merck & Co., Inc.: Company Recent Developments till Jan,2022
Table 270 Indian Immunologicals Ltd: Company Information
Table 271 Indian Immunologicals Ltd: Company Product and Service Benchmarking
Table 272 Indian Immunologicals Ltd: Company Recent Developments till Jan,2022
Table 273 Phibro Animal Health Corporation: Company Information
Table 274 Phibro Animal Health Corporation: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 275 Phibro Animal Health Corporation: Company Product and Service Benchmarking
Table 276 Biogenesis Bago SA: Company Information
Table 277 Biogenesis Bago SA: Company Product and Service Benchmarking
Table 278 Hester Biosciences Limited: Company Information
Table 279 Hester Biosciences Limited: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 280 Hester Biosciences Limited: Company Product and Service Benchmarking
Table 281 Hester Biosciences Limited: Company Recent Developments till Jan,2022
List of Figure
Figure 1 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 2 Global Veterinary Vaccines Market Segmentation
Figure 3 Current Market Dynamics in the Global Market
Figure 4 Veterinary Vaccines Porter’s Five Forces.
Figure 5 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 6 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 7 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 8 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 9 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 10 Global Veterinary Vaccine Market Forecast by Region 2022, 2027, 2032 (%)
Figure 11 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%))
Figure 12 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 13 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 14 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 15 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 16 Global Veterinary Vaccine Market Forecast by Companion Animal 2022, 2027, 2032 (%)
Figure 17 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))
Figure 18 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 19 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 20 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 21 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 22 Global Veterinary Vaccine Market Forecast by Technology 2022, 2027, 2032 (%)
Figure 23 Construction of Recombinant Attenuated Virus
Figure 24 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))
Figure 25 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 26 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 27 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 28 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 29 Global Veterinary Vaccine Market Forecast by Type 2022, 2027, 2032 (%)
Figure 30 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))
Figure 31 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 32 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 33 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 34 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 35 Global Veterinary Vaccine Market Forecast by Livestock 2022, 2027, 2032 (%)
Figure 36 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))
Figure 37 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 38 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 39 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 40 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 41 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 42 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 43 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 44 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 45 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 46 North America Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 47 North America Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 48 North America Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 49 North America Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 50 North America Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 51 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))
Figure 52 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 53 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 54 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 55 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 56 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))
Figure 57 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 58 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 59 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 60 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 61 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))
Figure 62 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 63 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 64 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 65 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 66 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))
Figure 67 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 68 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 69 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 70 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 71 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 72 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 73 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 74 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 75 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 76 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 77 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 78 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 79 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 80 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 81 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 82 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 83 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 84 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 85 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 86 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 87 Europe Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 88 Europe Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 89 Europe Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 90 Europe Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 91 Europe Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 92 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))
Figure 93 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 94 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 95 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 96 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 97 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))
Figure 98 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 99 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 100 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 101 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 102 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))
Figure 103 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 104 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 105 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 106 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 107 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))
Figure 108 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 109 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 110 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 111 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 112 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 113 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 114 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 115 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 116 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 117 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 118 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 119 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 120 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 121 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 122 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 123 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 124 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 125 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 126 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 127 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 128 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 129 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 130 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 131 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 132 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 133 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 134 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 135 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 136 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 137 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 138 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 139 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 140 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 141 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 142 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 143 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 144 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 145 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 146 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 147 Asia-Pacific Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 148 Asia-Pacific Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 149 Asia-Pacific Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 150 Asia-Pacific Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 151 Asia-Pacific Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 152 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))
Figure 153 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 154 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 155 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 156 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 157 Asia-Pacific Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))
Figure 158 Asia-Pacific Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 159 Asia-Pacific Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 160 Asia-Pacific Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 161 Asia-Pacific Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 162 Asia-Pacific Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))
Figure 163 Asia-Pacific Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 164 Asia-Pacific Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 165 Asia-Pacific Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 166 Asia-Pacific Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 167 Asia-Pacific Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))
Figure 168 Asia-Pacific Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 169 Asia-Pacific Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 170 Asia-Pacific Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 171 Asia-Pacific Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 172 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 173 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 174 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 175 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 176 China Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 177 China Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 178 China Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 179 China Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 180 China Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 181 India Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 182 India Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 183 India Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 184 India Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 185 India Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 186 Japan Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 187 Japan Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 188 Japan Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 189 Japan Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 190 Japan Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 191 South Korea Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 192 South Korea Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 193 South Korea Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 194 South Korea Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 195 South Korea Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 196 Australia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 197 Australia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 198 Australia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 199 Australia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 200 Australia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 201 Rest of Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 202 Rest of Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 203 Rest of Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 204 Rest of Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 205 Rest of Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 206 LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 207 LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 208 LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 209 LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 210 LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 211 LAMEA Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 212 LAMEA Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 213 LAMEA Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 214 LAMEA Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 215 LAMEA Veterinary Vaccines Market by Country, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 216 LAMEA Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))
Figure 217 LAMEA Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 218 LAMEA Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 219 LAMEA Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 220 LAMEA Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 221 LAMEA Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))
Figure 222 LAMEA Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 223 LAMEA Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 224 LAMEA Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 225 LAMEA Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 226 LAMEA Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))
Figure 227 LAMEA Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 228 LAMEA Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 229 LAMEA Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 230 LAMEA Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 231 LAMEA Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))
Figure 232 LAMEA Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 233 LAMEA Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 234 LAMEA Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 235 LAMEA Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 236 Brazil Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 237 Brazil Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 238 Brazil Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 239 Brazil Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 240 Brazil Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 241 South Africa Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 242 South Africa Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 243 South Africa Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 244 South Africa Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 245 South Africa Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 246 Saudi Arabia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 247 Saudi Arabia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 248 Saudi Arabia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 249 Saudi Arabia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 250 Saudi Arabia Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 251 Turkey Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 252 Turkey Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 253 Turkey Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 254 Turkey Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 255 Turkey Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 256 UAE Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 257 UAE Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 258 UAE Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 259 UAE Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 260 UAE Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 261 Rest of LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 262 Rest of LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 263 Rest of LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 264 Rest of LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 265 Rest of LAMEA Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 266 Zoetis Inc: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 267 Zoetis Inc: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 268 Zoetis Inc: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 269 Zoetis Inc: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 270 Virbac SA : Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 271 Virbac SA : Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 272 Virbac SA : Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 273 Virbac SA : Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 274 Elanco Animal Health Incorporated: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 275 Elanco Animal Health Incorporated: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 276 Elanco Animal Health Incorporated: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 277 Elanco Animal Health Incorporated: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 278 Merck & Co., Inc.: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 279 Merck & Co., Inc.: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 280 Merck & Co., Inc.: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 281 Merck & Co., Inc.: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 282 Phibro Animal Health Corporation: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 283 Phibro Animal Health Corporation: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 284 Phibro Animal Health Corporation: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 285 Phibro Animal Health Corporation: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 286 Hester Biosciences Limited: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 287 Hester Biosciences Limited: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 288 Hester Biosciences Limited: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 289 Hester Biosciences Limited: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 290 Global Veterinary Vaccine Market Forecast by Region 2022, 2027, 2032 (%)
List of Companies Profiled in the report
Biogenesis Bago SA
Boehringer Ingelheim Animal Health
Elanco Animal Health Incorporated
Hester Biosciences
Hipra Pharmaceutical Company
Indian Immunologicals Ltd (IIL)
Intas Pharmaceuticals Ltd
Merck Animal Health
Phibro Animal Health Corporation (Phibro)
Virbac Pharmaceutical
Zoetis Inc.
List of Other Companies Mentioned in the report
AbbVie
Allevi
AMRI
Anacor
Arabio
AstraZeneca
Avid Bioservices
Baxter BioPharma Solutions
Baxter International Inc.
Beijing Tiantan Biological Products
BioKangtai
BioNTech
Bit Bio
Boehringer Ingelheim Biopharmaceuticals Gmbh
Bristol-Myers Squibb
Catalent, Inc.
Charles River Laboratories
DiNAQOR AG
Galderma
Gardasil
GE Healthcare
GenePOC Inc.
GlaxoSmithKline
GSAL
HemaCare Corporation
Hospira
IDT Biologika GmbH
Indapta Therapeutics
JSR Life Sciences
KBI Biopharma
LONZA
MaSTherCell (a Catalent company)
Merck KGaA
Meridian Life Science
Navrogen Inc.
Novartis
Pfizer CentreOne
Pfizer Inc.
PRA Health Sciences
Roche
Sanofi S.A.
Spirig Pharma
ThermoVax
Zumutor Biologics, Inc.
List of Associations Mentioned in the Report
Biomedical Advanced Research and Development Authority (BARDA)
Center for Disease Control (CDC)
Centers for Disease Control and Prevention
China Food and Drug Administration (CFDA)
Contract Pharma Outsourcing Survey
Defense Advanced Research Projects Agency (DARPA)
Department of Health and Human Services (HHS)
Emory University
European Medical Agency
Food and Drug Administration (FDA)
Global Vaccine Action Plan
Government of Canada
Gulf Cooperation Council Member States
National Institute of Allergy and Infectious Diseases (NIAID)
PATH
U.S. Department of Health and Human Services Office
U.S. Department of Homeland Security
United Nations Children's Fund
World Health Assembly
World Health Organisation (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
